Corcept Therapeutics (CORT) Property, Plant & Equipment (Net) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Corcept Therapeutics | 7.26 Bn | 6.92 Bn | 162.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.45% |
| Dec 31, 2025 | 2.44% |
| Sep 30, 2025 | 9.82% |
| Jun 30, 2025 | 30.56% |
| Mar 31, 2025 | 23.64% |
| Dec 31, 2024 | 20.69% |
| Sep 30, 2024 | 19.02% |
| Jun 30, 2024 | 4.57% |
| Mar 31, 2024 | -32.77% |
| Dec 31, 2023 | -21.52% |
| Sep 30, 2023 | -10.97% |
| Jun 30, 2023 | -5.64% |
| Mar 31, 2023 | -4.39% |
| Dec 31, 2022 | 4.09% |
| Sep 30, 2022 | 7.69% |
| Jun 30, 2022 | 11.55% |
| Mar 31, 2022 | 19.18% |
| Dec 31, 2021 | 37.35% |
| Sep 30, 2021 | 53.26% |
| Jun 30, 2021 | 79.44% |
| Mar 31, 2021 | 73.95% |
| Dec 31, 2020 | 76.42% |
| Sep 30, 2020 | 55.76% |
| Jun 30, 2020 | 29.04% |
| Mar 31, 2020 | 30.78% |
| Dec 31, 2019 | 34.79% |
| Sep 30, 2019 | 35.06% |
| Jun 30, 2019 | 31.79% |
| Mar 31, 2019 | 26.55% |
| Dec 31, 2018 | 26.40% |
| Sep 30, 2018 | 24.03% |
| Jun 30, 2018 | 31.76% |
| Mar 31, 2018 | 30.24% |
| Dec 31, 2017 | 28.13% |
| Sep 30, 2017 | 39.41% |
| Jun 30, 2017 | 53.27% |
| Mar 31, 2017 | 58.70% |
| Dec 31, 2016 | 51.13% |
| Sep 30, 2016 | 117.19% |
| Jun 30, 2016 | 90.87% |
| Dec 31, 2015 | 89.60% |